SCIMEDX PHASE II MPO IGG ANTIBODY EIA (1281)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II MPO IGG ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-myeloperoxidase (MPO) antibodies (K010289 | K010289) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Scimedx HEp2 ANA IFAView Complexity
Abbott AerosetView Complexity
VITROS 4600 Chemistry SystemView Complexity
MarDx Anti-Thyroid Antibody Test SystemView Complexity
Roche Diagnostics Elecsys 2010View Complexity
Beckman ICSView Complexity
EUROIMMUN Euroline M2-3EView Complexity
Quest International SeraQuest Anti-Sm/RNPView Complexity
Roche Diagnostics Hitachi 704View Complexity
Quest International SeraQuest Anti-SmView Complexity